These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


515 related items for PubMed ID: 17416215

  • 1. A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis.
    Floreani A, Carderi I, Ferrara F, Rizzotto ER, Luisetto G, Camozzi V, Baldo V.
    Dig Liver Dis; 2007 Jun; 39(6):544-8. PubMed ID: 17416215
    [Abstract] [Full Text] [Related]

  • 2. Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study.
    Benetti A, Crosignani A, Varenna M, Giussani CS, Allocca M, Zuin M, Podda M, Battezzati PM.
    J Clin Gastroenterol; 2008 Mar; 42(3):306-11. PubMed ID: 18223492
    [Abstract] [Full Text] [Related]

  • 3. Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment.
    Crippin JS, Jorgensen RA, Dickson ER, Lindor KD.
    Am J Gastroenterol; 1994 Jan; 89(1):47-50. PubMed ID: 8273797
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK, Chadha M, Modi KD, Kumar KM, Mehrotra R, Sriram U.
    J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
    [Abstract] [Full Text] [Related]

  • 5. Antiresorption therapy and reduction in fracture susceptibility in the osteoporotic elderly patient: open study.
    Muscoso E, Puglisi N, Mamazza C, Lo Giudice F, Testai M, Abbate S, Santangelo A, Panebianco P, Maugeri D.
    Eur Rev Med Pharmacol Sci; 2004 Jun; 8(2):97-102. PubMed ID: 15267123
    [Abstract] [Full Text] [Related]

  • 6. Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease.
    Bernstein CN, Bector S, Leslie WD.
    Am J Gastroenterol; 2003 Nov; 98(11):2468-73. PubMed ID: 14638350
    [Abstract] [Full Text] [Related]

  • 7. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements.
    Gulati S, Sharma RK, Gulati K, Singh U, Srivastava A.
    Nephrol Dial Transplant; 2005 Aug; 20(8):1598-603. PubMed ID: 15956073
    [Abstract] [Full Text] [Related]

  • 8. Effect of raloxifene and clodronate on bone density in postmenopausal osteoporotic women.
    D'Amelio P, Muratore M, Tinelli F, Tamone C, Cosentino L, Quarta E, Calcagnile F, Carlo Isaia G.
    Int J Tissue React; 2003 Aug; 25(2):73-8. PubMed ID: 14518596
    [Abstract] [Full Text] [Related]

  • 9. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.
    Dawson-Hughes B, Harris SS, Krall EA, Dallal GE.
    N Engl J Med; 1997 Sep 04; 337(10):670-6. PubMed ID: 9278463
    [Abstract] [Full Text] [Related]

  • 10. Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis.
    Camisasca M, Crosignani A, Battezzati PM, Albisetti W, Grandinetti G, Pietrogrande L, Biffi A, Zuin M, Podda M.
    Hepatology; 1994 Sep 04; 20(3):633-7. PubMed ID: 8076921
    [Abstract] [Full Text] [Related]

  • 11. Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease.
    Benchimol EI, Ward LM, Gallagher JC, Rauch F, Barrowman N, Warren J, Beedle S, Mack DR.
    J Pediatr Gastroenterol Nutr; 2007 Nov 04; 45(5):538-45. PubMed ID: 18030230
    [Abstract] [Full Text] [Related]

  • 12. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA, Kendall MA, Tebas P, Swindells S, Hogg E, Alston-Smith B, Suckow C, Gopalakrishnan G, Benson C, Wohl DA.
    AIDS; 2007 Nov 30; 21(18):2473-82. PubMed ID: 18025884
    [Abstract] [Full Text] [Related]

  • 13. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study.
    Millonig G, Graziadei IW, Eichler D, Pfeiffer KP, Finkenstedt G, Muehllechner P, Koenigsrainer A, Margreiter R, Vogel W.
    Liver Transpl; 2005 Aug 30; 11(8):960-6. PubMed ID: 16035083
    [Abstract] [Full Text] [Related]

  • 14. Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis.
    Haworth CS, Jones AM, Adams JE, Selby PL, Webb AK.
    J Cyst Fibros; 2004 Dec 30; 3(4):233-6. PubMed ID: 15698940
    [Abstract] [Full Text] [Related]

  • 15. Bone mineral density changes in women with systemic lupus erythematosus.
    Boyanov M, Robeva R, Popivanov P.
    Clin Rheumatol; 2003 Oct 30; 22(4-5):318-23. PubMed ID: 14579164
    [Abstract] [Full Text] [Related]

  • 16. Ten-year follow-up of 3 years of oral adjuvant clodronate therapy shows significant prevention of osteoporosis in early-stage breast cancer.
    Saarto T, Vehmanen L, Blomqvist C, Elomaa I.
    J Clin Oncol; 2008 Sep 10; 26(26):4289-95. PubMed ID: 18779616
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of vertebral alterations and the effects of calcium and vitamin D supplementation on calcium metabolism and bone mineral density after gastrectomy.
    Glatzle J, Piert M, Meile T, Besenthal I, Schäfer JF, Königsrainer A, Zittel TT.
    Br J Surg; 2005 May 10; 92(5):579-85. PubMed ID: 15779069
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis.
    Menon KV, Angulo P, Boe GM, Lindor KD.
    Am J Gastroenterol; 2003 Apr 10; 98(4):889-92. PubMed ID: 12738473
    [Abstract] [Full Text] [Related]

  • 19. Effect of pamidronate on bone loss after kidney transplantation: a randomized trial.
    Walsh SB, Altmann P, Pattison J, Wilkie M, Yaqoob MM, Dudley C, Cockwell P, Sweny P, Banks LM, Hall-Craggs M, Noonan K, Andrews C, Cunningham J.
    Am J Kidney Dis; 2009 May 10; 53(5):856-65. PubMed ID: 19393473
    [Abstract] [Full Text] [Related]

  • 20. The effect of low-dose cholecalciferol and calcium treatment on posttransplant bone loss in renal transplant patients: a prospective study.
    Sahin G, Yasar NS, Sirmagul B, Bal C, Yalcin AU.
    Ren Fail; 2008 May 10; 30(10):992-9. PubMed ID: 19016151
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.